The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian Sanchez, MD
J & J Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arrhythmia Institute at Grandview
Birmingham, Alabama, United States
Anil Rajendra, MDRecruiting - Mobile Cardiology Associates
Mobile, Alabama, United States
Matthew E Quin, MDRecruiting - Community Memorial Health System
Ventura, California, United States
Jonathan Dukes, MDRecruiting - Medical City - Hca
Aurora, Colorado, United States
Christopher Porterfield, MDRecruiting - Naples Community Hospital
Naples, Florida, United States
Withdrawn - Sarasota Memorial Health
Sarasota, Florida, United States
Antonio Moretta, MDRecruiting - Piedmont Healthcare
Atlanta, Georgia, United States
Sandeep Goyal, MDRecruiting - Norton Heart and Vascular Institute
Louisville, Kentucky, United States
Kent Morris, MDRecruiting - the Brigham and Womens Hospital
Boston, Massachusetts, United States
Jorge Romero, MDNot, yet, recruiting - Sparrow Clinical Research Institute
Lansing, Michigan, United States
Ali Sheikh, DORecruiting - Trinity Health-Michigan Heart
Ypsilanti, Michigan, United States
Mohammad-Ali Jazayeri, MDRecruiting - the Christ Hospital
Cincinnati, Ohio, United States
Alexandru Costea, MDRecruiting - University of Cincinnati
Cincinnati, Ohio, United States
Srinivas Rajsheker, MDRecruiting - University of Pennsylvania (upenn)
Philadelphia, Pennsylvania, United States
Benjamin D'Souza, MDRecruiting - Allegheny Health
Pittsburgh, Pennsylvania, United States
Joshua Silverstein, MDRecruiting - Centra Health, Inc.Dba Stroobants Cardiovascular Center
Lynchburg, Virginia, United States
Mathhew SackettRecruiting - Bon Secours Medical Group - Richmond Specialty Care
Richmond, Virginia, United States
An Bui, MDRecruiting - Valley Health System
Winchester, Virginia, United States
Emmanuel Ekanem, MDRecruiting - Multicare Health Systems-Pulse Heart
Puyallup, Washington, United States
Tariq Salam, MDRecruiting - Franciscan Heart and Vascular Associates
Tacoma, Washington, United States
Nasir Shariff, MDRecruiting - Mercy Health
Janesville, Wisconsin, United States
Imdad AhmedRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Feb 2024
- Primary completion
- 31 Mar 2026
- Completion
- 31 Mar 2028
- Last update posted
- 31 Oct 2025
- Registered enrollment
- 250
- Registry id
- NCT06324201
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.